课题基金 / 基金详情

CORE--CLINICAL INVESTIGATIONS SUPPORT FACILITY

CORE--CLINICAL INVESTIGATIONS SUPPORT FACILITY
核心——临床研究支持设施
批准号:
6443826
负责人:
DARCY V SPICER
金额:
$9.16万
依托单位国家:
美国
项目类别:
财政年份:
1980
资助国家:
美国
项目状态:
已结题
起止时间:
1980-04-01 至 2005-11-30

项目摘要

项目成果

DARCY V SPICER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Clinical Investigations Support Office (CISO) was established to provide investigators at the USC/Norris Comprehensive Cancer Center services, technologies and scientific consultation to enhance scientific productivity and foster interdisciplinary interaction and research. CISO is a centralized organization of individuals with specific and specialized roles in clinical trials development and administration. CISO provides a centralized administration for protocol development, review, prioritization, regulatory compliance, study conduct and monitoring and quality assurance. This shared resource has two components: a centralized Protocol Administration Unit and a Research Nursing/Data Management Unit. The centralized administration of clinical research activities is critical to the efficient conduct of clinical trials at the Cancer Center. The CISO protocol and data management system provides the centralized support services necessary for the conduct of externally- funded and internally peer-reviewed and monitored research clinical trials. CISO is tightly integrated with the operations of the Clinical Investigations Committee and the Quality Assurance Committee. CISO maintains all protocols and regulatory documents, distributes protocols, provides centralized data quality control and oversight, and maintenance of protocols databases. The Research Nursing/Data Management Unit provides the centralized function of advising and assisting investigators in patient eligibility assessments, data quality control and oversight. CISO occupies a suite of offices located on the 7th floor o the Topping Tower and satellite space located in proximity to patient treatment areas at the Los Angeles County+USC Medical Center.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SCCISARS 2: An e-Solution to Protect Human Subjects
A PHASE I STUDY OF THE GARFT INHIBITOR AG2034 IN PATIENTS WITH ADVANCED CANCER
PHASE II RANDOMIZED STUDY OF PACLITAXEL VS PACLITAXEL+PSC833 FOR BREAST CANCER
PHASE II RANDOMIZED STUDY OF PACLITAXEL VS PACLITAXEL+PSC833 FOR BREAST CANCER
海外基金